ENTX Entera Bio Ltd. - Ordinary Shares
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 7, 2026
$2,86
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,91mínimo 52 semanas
$4,20máximo 52 semanas
Capitalización Bursátil (MRQ)
$141M
P/E (TTM)
8.4
BPA (TTM)
$0.34
Ingresos (TTM)
$0
tus insignias
Rango 52S
$1–$4
Calificación del Analista
BUY
Precio Objetivo
$10
P/E
8.4
ROE
-138.9%
Margen de Beneficio Neto
-27235.7%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
ENTX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.86
Capitalización Bursátil (MRQ)
$141M
P/E (TTM)
8.4
BPA (TTM)
$0.34
Ingresos (TTM)
$0
ROE (TTM)
-138.9%
Rango 52S
$1–$4
ENTX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$42.0K2018-12-31 → 2025-12-31
BPA$0.252016-12-31 → 2025-12-31
Flujo de caja libre$-7M2018-12-31 → 2025-12-31
Margen neto-27235.7%2018-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | ENTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 8.4promedio 5A ≈5.2 | ≈5.2 | · | · | |
| P/S | 3144.5promedio 5A ≈915.0 | ≈915.0 | · | · | |
| P/C (MRQ) | 19.4promedio 5A ≈5.2 | ≈5.2 | · | · | |
| Precio / FCF (TTM) | -12.9promedio 5A ≈-7.2 | ≈-7.2 | · | · | |
| Precio / Flujo de Caja (TTM) | -12.9promedio 5A ≈-7.2 | ≈-7.2 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 10.1promedio 5A ≈4.9 | ≈4.9 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | ENTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Gross Margin (Margen Bruto) | 0.00%promedio 5A ≈9.9% | ≈9.9% | 64.8% | Débil | |
| Operating Margin (Margen Operativo) | -27450.0%promedio 5A ≈-14153.3% | ≈-14153.3% | 7.3% | Débil | |
| EBITDA Margin (Margen EBITDA) | -27450.0%promedio 5A ≈-14153.3% | ≈-14153.3% | 7.9% | Débil | |
| Pretax Margin (Margen antes de impuestos) | -27235.7%promedio 5A ≈-14050.5% | ≈-14050.5% | 0.48% | Débil | |
| Net Profit Margin (Margen de Beneficio Neto) | -27235.7%promedio 5A ≈-14087.2% | ≈-14087.2% | -4.3% | Débil | |
| ROA (TTM) | -87.0%promedio 5A ≈-79.6% | ≈-79.6% | -28.9% | Débil | |
| ROE (TTM) | -138.9%promedio 5A ≈-103.5% | ≈-103.5% | 26.2% | Débil | |
| ROIC | -88.0%promedio 5A ≈-101.2% | ≈-101.2% | -39.8% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | ENTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 9.0promedio 5A ≈8.6 | ≈8.6 | 5.3 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 3.2promedio 5A ≈7.5 | ≈7.5 | 3.8 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | ENTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -76.8%promedio 5A ≈-32.3% | ≈-32.3% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -32.1% | · | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | -35.1% | · | · | · | |
| EPS YoY (EPS interanual) | 0.00%promedio 5A ≈-13.7% | ≈-13.7% | · | · | |
| EPS CAGR 3Y (CAGR BPA 3A) | -17.8% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | ENTX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.5 | Débil | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 0.7promedio 5A ≈1.0 | ≈1.0 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$2.1K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
17.0%
Próximo informe
Nov 12, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 7, 2026 | $-0.14 | $-0.08 | -71.6% |
| 31 de marzo de 2026 | May 8, 2026 | $-0.07 | $-0.15 | 54.2% |
| 31 de diciembre de 2025 | $-0.07 | $-0.09 | 23.7% | |
| 30 de septiembre de 2025 | $-0.07 | $-0.09 | 23.7% | |
| 30 de junio de 2025 | $-0.06 | $-0.11 | 46.5% | |
| 31 de marzo de 2025 | $-0.06 | $-0.07 | 16.0% | |
| 31 de diciembre de 2024 | $-0.06 | $-0.08 | 26.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42.0K | $181.0K | $0 | $134.0K | $571.0K | $365.0K | $236.0K | $500.0K | |
| Cost of Revenue | $42.0K | $172.0K | $0 | $101.0K | $373.0K | $300.0K | $210.0K | · | |
| Gross Profit | $0 | $9.0K | $0 | $33.0K | $198.0K | $65.0K | · | · | |
| R&D Expense | $6M | $4M | $5M | $6M | $7M | $6M | $7M | $9M | |
| SG&A Expense | $398.0K | $340.0K | $4M | $7M | $6M | $5M | $4M | $3M | |
| Operating Expenses | $12M | $10M | $9M | $13M | $12M | $11M | · | · | |
| Operating Income | $-12M | $-10M | $-9M | $-13M | $-12M | $-11M | $-11M | $-11M | |
| Other Non-op | $90.0K | $58.0K | $31.0K | $83.0K | $-29.0K | $-28.0K | · | · | |
| Pretax Income | $-11M | $-10M | $-9M | $-13M | $-12M | $-11M | $-11M | $-10M | |
| Income Tax | $0 | $14.0K | $29.0K | $137.0K | $-59.0K | $20.0K | · | · | |
| Net Income | $-11M | $-10M | $-9M | $-13M | $-12M | $-11M | $-11M | $-10M | |
| EPS (Basic) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.54 | $0.89 | $1.30 | |
| EPS (Diluted) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.55 | $0.89 | $1.31 | |
| Shares (Basic) | 46,191,067 | 37,650,179 | 29,007,794 | 28,808,090 | 26,133,770 | 18,417,093 | 12,146,729 | 7,955,447 | |
| Shares (Diluted) | 46,191,067 | 37,650,179 | 29,007,794 | 28,808,090 | 26,133,770 | 18,563,675 | 12,146,729 | 7,983,402 | |
| EBITDA | $-12M | $-10M | $-9M | $-13M | · | $-11M | $-11M | $-11M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $9M | $11M | $12M | $25M | $9M | $15M | $8M | |
| Receivables | $0 | $126.0K | $0 | $246.0K | $183.0K | $255.0K | $278.0K | $725.0K | |
| Prepaid Expense | $415.0K | $29.0K | $238.0K | $294.0K | · | · | · | · | |
| Other Current Assets | $107.0K | $186.0K | $238.0K | $294.0K | $254.0K | $261.0K | · | · | |
| Current Assets | $15M | $9M | $11M | $13M | $25M | $9M | $16M | $12M | |
| PP&E (Net) | $134.0K | $57.0K | $100.0K | $139.0K | $156.0K | $192.0K | $202.0K | $224.0K | |
| Intangibles | · | · | · | · | · | $605.0K | $605.0K | $651.0K | |
| Total Assets | $16M | $9M | $12M | $13M | $26M | $10M | $17M | $13M | |
| Accounts Payable | $448.0K | $132.0K | $83.0K | $17.0K | $166.0K | $164.0K | $1M | $1M | |
| Current Liabilities | $2M | $1M | $1M | $1M | $3M | $2M | $5M | $3M | |
| Capital Leases | $260.0K | $102.0K | $256.0K | $0 | $123.0K | $243.0K | · | · | |
| Other Non-current Liabilities | $393.0K | $0 | · | · | · | · | · | · | |
| Total Liabilities | $3M | $1M | $1M | $1M | $3M | $2M | $5M | $3M | |
| Common Stock | $1.0K | $1.0K | $1.0K | · | · | · | · | · | |
| Retained Earnings | $-125M | $-114M | $-104M | $-95M | $-82M | $-70M | $-63M | $-52M | |
| AOCI | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | · | · | |
| Stockholders' Equity | $13M | $8M | $10M | $12M | $23M | $8M | $14M | $10M | |
| Liabilities + Equity | $16M | $9M | $12M | $13M | $26M | $10M | · | · | |
| Shares Outstanding | 46,178,630 | 38,837,220 | 35,476,341 | 28,809,922 | 28,804,411 | 21,057,922 | · | · |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $225.0K | $238.0K | $54.0K | |
| Stock-based Comp | $3M | $3M | $2M | $2M | $2M | $901.0K | · | · | |
| Deferred Tax | $0 | $14.0K | $29.0K | $174.0K | $-217.0K | $0 | · | · | |
| Other Non-cash | · | · | · | · | · | $-665.0K | $2M | $454.0K | |
| Operating Cash Flow | $-7M | $-7M | $-7M | $-12M | $-9M | $-11M | $-9M | $-10M | |
| CapEx | $107.0K | $3.0K | $17.0K | $47.0K | $17.0K | $53.0K | $40.0K | $68.0K | |
| Investing Cash Flow | $-107.0K | $-3.0K | $-17.0K | $-102.0K | $-17.0K | $-53.0K | $4M | $-4M | |
| Stock Issued | $6M | $4M | $5.0K | $0 | $22M | $3M | · | · | |
| Net Stock Activity | $6M | $4M | $5.0K | $0 | · | · | · | · | |
| Financing Cash Flow | $14M | $4M | $6M | $13.0K | $25M | $4M | $13M | $10M | |
| Net Change in Cash | $6M | $-2M | $-1M | $-13M | $16M | $-7M | · | · | |
| Taxes Paid | · | · | $0 | $165.0K | $2.0K | $89.0K | · | · | |
| Free Cash Flow | $-7M | $-7M | $-7M | $-13M | · | $-10M | $-9M | $-10M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.00% | 5.0% | · | 24.6% | · | · | · | · | |
| Operating Margin | -27450.0% | -5295.6% | · | -9714.2% | · | -3050.1% | -4853.4% | -2172.2% | |
| Net Margin | -27235.7% | -5271.3% | · | -9754.5% | · | -2735.1% | -4574.2% | -2060.8% | |
| Pretax Margin | -27235.7% | -5263.5% | · | -9652.2% | · | -2729.6% | · | · | |
| EBITDA Margin | -27450.0% | -5295.6% | · | -9714.2% | · | -2988.5% | -4752.5% | -2161.4% | |
| ROA | -90.1% | -90.2% | -71.4% | -66.8% | · | -74.0% | -71.9% | -77.4% | |
| ROE | -75.4% | -131.3% | -106.9% | -100.3% | · | -97.7% | -98.0% | 96.1% | |
| ROIC | -88.0% | -118.8% | -85.9% | -111.9% | · | -167.4% | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | 7.6 | 10.3 | 9.6 | · | 2.8 | 3.4 | 7.0 | |
| Quick Ratio | 3.2 | 7.5 | 10.1 | 9.4 | · | 2.7 | 3.4 | 4.6 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 0.7 | 2.9 | 0.0 | 0.6 | · | 1.4 | 0.5 | 1.4 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.28 | $0.21 | $0.29 | $0.41 | · | · | · | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.02 | $0.02 | $0.06 | |
| Cash Flow / Share | $-0.16 | $-0.18 | $-0.25 | $-0.43 | · | $-0.56 | $-0.73 | $-1.23 | |
| Cash / Share | $0.15 | $0.22 | $0.31 | $0.43 | · | · | · | · | |
| EPS (TTM) | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.55 | $0.89 | $1.31 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -76.8% | · | · | -76.5% | 56.4% | · | · | · | |
| Revenue CAGR 3Y | -32.1% | -31.8% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -35.1% | · | · | · | · | · | · | · | |
| EPS YoY | 0.00% | -19.4% | -31.1% | -4.3% | · | · | · | · | |
| EPS CAGR 3Y | -17.8% | -19.0% | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42.0K | $181.0K | $0 | $134.0K | $571.0K | $365.0K | $236.0K | $500.0K | |
| Net Income TTM | $-11M | $-10M | $-9M | $-13M | $-12M | $-11M | $-11M | $-10M | |
| Market Cap | $90M | $82M | $21M | $21M | · | · | · | · | |
| P/E | 7.8 | 8.5 | 1.9 | 1.6 | 6.0 | 2.0 | 2.4 | 2.3 | |
| P/S | 2133.0 | 454.9 | · | 156.9 | · | · | · | · | |
| P/B | 6.8 | 10.2 | 2.0 | 1.8 | · | · | · | · | |
| P / Tangible Book | 6.8 | 10.2 | 2.0 | 1.8 | 3.6 | · | · | · | |
| P / Cash Flow | -12.2 | -12.1 | -2.9 | -1.7 | · | · | · | · | |
| P / FCF | -12.0 | -12.1 | -2.9 | -1.7 | · | · | · | · | |
| Earnings Yield | 12.9% | 11.8% | 51.7% | 61.6% | 16.7% | 50.9% | 41.6% | 43.0% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $42.0K | $82.0K | $42.0K | $57.0K | $0 | $0 | $0 | $0 | $0 | $14.0K | $8.0K | |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $42.0K | $82.0K | $42.0K | $48.0K | $0 | $0 | $0 | $0 | $0 | $8.0K | $6.0K | |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $9.0K | · | $0 | $0 | $0 | $0 | $6.0K | $2.0K | |
| R&D Expense | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $735.0K | $1M | $1M | $1M | $931.0K | $1M | $1M | |
| SG&A Expense | $124.0K | $128.0K | $-1M | $122.0K | $103.0K | $123.0K | $-1M | $62.0K | $134.0K | $1M | $973.0K | $1M | $1M | $1M | $2M | $1M | |
| Operating Expenses | $5M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Operating Income | $-5M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | |
| Other Non-op | $-3M | $34.0K | $26.0K | $56.0K | $12.0K | $-4.0K | $-7.0K | $0 | $20.0K | $45.0K | $-32.0K | $36.0K | $5.0K | $22.0K | $-13.0K | $-8.0K | |
| Pretax Income | · | · | · | · | · | · | $-2M | $-3M | · | · | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | |
| Income Tax | · | · | · | · | · | · | $14.0K | $0 | · | · | $0 | $29.0K | $0 | $0 | $-46.0K | $194.0K | |
| Net Income | $-7M | $-4M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M | |
| EPS (Basic) | $0.14 | $0.07 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | $0.08 | $0.06 | $0.05 | $0.07 | $0.08 | $0.08 | $0.08 | $0.10 | $0.11 | |
| EPS (Diluted) | $0.14 | $0.07 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | $0.08 | $0.06 | $0.05 | $0.07 | $0.08 | $0.08 | $0.08 | $0.10 | $0.11 | |
| Shares (Basic) | 50,451,232 | 47,756,409 | · | 47,089,814 | 46,836,700 | 43,377,391 | · | 37,644,612 | 37,090,160 | 36,735,429 | · | 28,813,952 | 28,812,375 | 28,809,922 | · | 28,809,922 | |
| Shares (Diluted) | 50,451,232 | 47,756,409 | · | 47,089,814 | 46,836,700 | 43,377,391 | · | 37,644,612 | 37,090,160 | 36,735,429 | · | 28,813,952 | 28,812,375 | 28,809,922 | · | 28,809,922 | |
| EBITDA | $-5M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $4M | $7M | $9M | $11M | $13M | $9M | $7M | $9M | $9M | $11M | $8M | $9M | $11M | $12M | $14M | |
| Receivables | · | · | $0 | $0 | $0 | $126.0K | $126.0K | $42.0K | $57.0K | · | $0 | $0 | $29.0K | $29.0K | $246.0K | $233.0K | |
| Prepaid Expense | $465.0K | $566.0K | $37.0K | $405.0K | $438.0K | $519.0K | $29.0K | $383.0K | $482.0K | $562.0K | · | $431.0K | $650.0K | · | · | · | |
| Other Current Assets | $144.0K | $256.0K | $415.0K | $262.0K | $192.0K | $165.0K | $186.0K | $89.0K | $67.0K | $39.0K | $238.0K | $263.0K | $354.0K | $653.0K | $294.0K | $634.0K | |
| Current Assets | $19M | $12M | $15M | $17M | $19M | $21M | $9M | $7M | $10M | $10M | $11M | $8M | $10M | $11M | $13M | $15M | |
| PP&E (Net) | $121.0K | $127.0K | $134.0K | $114.0K | $79.0K | $57.0K | $57.0K | $65.0K | $76.0K | $87.0K | $100.0K | $108.0K | $122.0K | $136.0K | $139.0K | $152.0K | |
| Total Assets | $19M | $13M | $16M | $17M | $20M | $22M | $9M | $8M | $10M | $10M | $12M | $9M | $10M | $12M | $13M | $16M | |
| Accounts Payable | $575.0K | $274.0K | $448.0K | $216.0K | $383.0K | $134.0K | $132.0K | $184.0K | $69.0K | $66.0K | $83.0K | $564.0K | $240.0K | $150.0K | $17.0K | $413.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | |
| Capital Leases | $226.0K | $263.0K | $260.0K | $41.0K | $9.0K | $51.0K | $102.0K | $147.0K | $179.0K | $224.0K | $256.0K | $271.0K | $316.0K | · | $0 | $3.0K | |
| Other Non-current Liabilities | · | · | $393.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $12M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $1M | $1M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | · | · | · | · | |
| Retained Earnings | $-136M | $-129M | $-125M | $-122M | $-119M | $-116M | $-114M | $-112M | $-109M | $-106M | $-104M | $-102M | $-100M | $-98M | $-95M | $-92M | |
| AOCI | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | $41.0K | |
| Stockholders' Equity | $7M | $11M | $13M | $15M | $17M | $19M | $8M | $6M | $9M | $9M | $10M | $6M | $8M | $10M | $12M | $14M | |
| Liabilities + Equity | $19M | $13M | $16M | $17M | $20M | $22M | $9M | $8M | $10M | $10M | $12M | $9M | $10M | $12M | $13M | $16M | |
| Shares Outstanding | 49,290,233 | 46,622,239 | 46,178,630 | 45,664,506 | 45,452,167 | 45,420,677 | 38,837,220 | 36,512,214 | 36,314,579 | 35,526,281 | 35,476,341 | 28,813,952 | 28,813,952 | 28,809,922 | 28,809,922 | 28,809,922 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $624.0K | $672.0K | $710.0K | $927.0K | $509.0K | $604.0K | $566.0K | $928.0K | $598.0K | $464.0K | $318.0K | $383.0K | $472.0K | $516.0K | $477.0K | $110.0K | |
| Deferred Tax | · | · | · | · | · | · | $14.0K | · | · | · | $0 | $29.0K | $0 | $0 | $23.0K | $214.0K | |
| Operating Cash Flow | $-3M | $-3M | $-2M | $-3M | $-2M | $-1M | $-1M | $-2M | $-1M | $-2M | $-3M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| CapEx | $3.0K | $0 | $27.0K | $43.0K | $29.0K | $8.0K | $3.0K | $0 | $0 | $0 | $5.0K | $0 | $1.0K | $11.0K | $3.0K | $2.0K | |
| Investing Cash Flow | $-3.0K | $0 | $-27.0K | $-43.0K | $-29.0K | $-8.0K | $-3.0K | $0 | $0 | $0 | $-5.0K | $0 | $-1.0K | $-11.0K | $-3.0K | $-57.0K | |
| Stock Issued | $0 | $0 | $0 | $71.0K | $0 | $6M | $3M | $19.0K | $620.0K | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $6M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $10M | $130.0K | $174.0K | $250.0K | $-51.0K | $13M | $3M | $13.0K | $1M | $30.0K | $6M | $0 | $5.0K | $0 | $0 | $0 | |
| Net Change in Cash | · | · | · | · | $-2M | $12M | $2M | $-2M | $-119.0K | $-2M | $3M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Free Cash Flow | · | $-3M | · | · | · | $-1M | · | · | · | $-2M | · | · | · | $-2M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.00% | · | 0.00% | 15.8% | · | · | · | · | · | · | 25.0% | |
| Operating Margin | · | · | · | · | · | -6102.4% | · | -7192.9% | -3798.2% | · | · | · | · | · | · | -35812.5% | |
| Net Margin | · | · | · | · | · | -6111.9% | · | -7192.9% | -3763.2% | · | · | · | · | · | · | -38337.5% | |
| Pretax Margin | · | · | · | · | · | · | · | -7192.9% | · | · | · | · | · | · | · | -35912.5% | |
| EBITDA Margin | · | · | · | · | · | -6102.4% | · | -7192.9% | -3798.2% | · | · | · | · | · | · | -35812.5% | |
| ROA | -37.4% | -20.2% | · | -25.4% | -17.9% | -16.1% | · | -37.0% | -20.9% | -18.5% | · | -19.7% | -15.8% | -12.9% | · | -39.5% | |
| ROE | -59.6% | -23.3% | · | -29.5% | -20.6% | -18.2% | · | -47.6% | -25.6% | -21.3% | · | -23.2% | -18.2% | -14.7% | · | -42.9% | |
| ROIC | · | · | · | · | · | · | · | -46.8% | · | · | · | -38.7% | -28.3% | -21.9% | · | -21.4% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 7.9 | · | 10.8 | 10.5 | 13.1 | · | 6.6 | 7.4 | 8.7 | · | 4.0 | 5.3 | 7.6 | · | 12.7 | |
| Quick Ratio | 5.4 | 2.6 | · | 5.5 | 5.9 | 7.8 | · | 6.3 | 7.0 | 8.2 | · | 3.7 | 4.9 | 7.2 | · | 12.2 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.5 | · | 2.0 | 1.3 | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.15 | $0.23 | · | $0.33 | $0.38 | $0.43 | · | $0.18 | $0.23 | $0.25 | · | $0.22 | $0.29 | $0.35 | · | $0.50 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.03 | · | · | · | $-0.05 | · | · | · | $-0.06 | · | · | |
| Cash / Share | $0.23 | $0.09 | · | $0.19 | $0.24 | $0.28 | · | $0.19 | $0.25 | $0.26 | · | $0.26 | $0.32 | $0.37 | · | $0.50 | |
| EPS (TTM) | $0.34 | $0.26 | · | $0.25 | $0.26 | $0.26 | · | $0.26 | $0.26 | $0.28 | · | $0.34 | $0.37 | $0.40 | · | $0.50 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $124.0K | $166.0K | $223.0K | · | $99.0K | $57.0K | $0 | · | $14.0K | $22.0K | $66.0K | · | $285.0K | |
| Net Income TTM | $-17M | $-12M | · | $-11M | $-11M | $-10M | · | $-9M | $-9M | $-9M | · | $-10M | $-11M | $-11M | · | $-14M | |
| Market Cap | $87M | $52M | · | $88M | $86M | $77M | · | $69M | $67M | $59M | · | $21M | $24M | $33M | · | $30M | |
| P/E | 5.2 | 4.3 | · | 7.7 | 7.3 | 6.5 | · | 7.3 | 7.1 | 6.0 | · | 2.1 | 2.3 | 2.9 | · | 2.1 | |
| P/S | · | · | · | 707.1 | 520.2 | 346.3 | · | 700.7 | 1172.3 | · | · | 1492.2 | 1104.1 | 506.4 | · | 105.1 | |
| P/B | 12.0 | 4.8 | · | 5.8 | 5.0 | 4.0 | · | 10.8 | 7.8 | 6.7 | · | 3.3 | 3.0 | 3.3 | · | 2.1 | |
| P / Tangible Book | 12.0 | 4.8 | · | 5.8 | 5.0 | 4.0 | · | 10.8 | 7.8 | 6.7 | · | 3.3 | 3.0 | 3.3 | · | 2.1 | |
| P / Cash Flow | · | -16.7 | · | · | · | -55.0 | · | · | · | -31.9 | · | · | · | -20.8 | · | · | |
| Earnings Yield | 19.2% | 23.4% | · | 13.0% | 13.7% | 15.3% | · | 13.7% | 14.1% | 16.8% | · | 46.9% | 43.9% | 34.5% | · | 48.1% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $42.0K | $181.0K | $0 | $134.0K | $571.0K |
| Margen Bruto % | 0.00% | 5.0% | · | 24.6% | · |
| Margen Operativo % | -27450.0% | -5295.6% | · | -9714.2% | · |
| Beneficio neto | $-11M | $-10M | $-9M | $-13M | $-12M |
| EPS Diluido | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 6.9 | 7.6 | 10.3 | 9.6 | · |
| Ratio Rápido | 3.2 | 7.5 | 10.1 | 9.4 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-7M | $-7M | $-7M | $-13M | · |
Propietarios institucionales (13F) 29 declarantes · $18.8M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
29
Valor en tenencia
$18.8M
Nuevas posiciones
8
Posiciones cerradas
6
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 8 (0 vs trimestre anterior) | 6 (+2 vs trimestre anterior) | 8 (+3 vs trimestre anterior) | 6 (-1 vs trimestre anterior) | +2.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Knoll Capital Management, LLC | $10 410 925 | 5 881 879 | 55,39% | Acciones |
| BVF INC/IL | $4 292 250 | 2 425 000 | 22,84% | Acciones |
| Siren, L.L.C. | $1 303 529 | 736 457 | 6,94% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $652 859 | 368 847 | 3,47% | Acciones |
| Parkman Healthcare Partners LLC | $485 860 | 274 497 | 2,59% | Acciones |
| PNC Financial Services Group, Inc. | $483 265 | 273 031 | 2,57% | Acciones |
| Seven Fleet Capital Management LP | $338 697 | 191 354 | 1,80% | Acciones |
| HighTower Advisors, LLC | $132 935 | 74 573 | 0,71% | Acciones |
| Schonfeld Strategic Advisors LLC | $104 201 | 58 871 | 0,55% | Acciones |
| TWO SIGMA SECURITIES, LLC | $86 010 | 48 593 | 0,46% | Acciones |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | $83 771 | 47 328 | 0,45% | Acciones |
| CITADEL ADVISORS LLC | $68 683 | 38 804 | 0,37% | Acciones |
| JPMORGAN CHASE & CO | $67 457 | 40 883 | 0,36% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $52 937 | 29 908 | 0,28% | Acciones |
| DIADEMA PARTNERS LP | $41 170 | 23 260 | 0,22% | Acciones |
| XTX Topco Ltd | $36 389 | 20 559 | 0,19% | Acciones |
| Gem Investment Advisors, LLC | $33 869 | 19 135 | 0,18% | Acciones |
| JANE STREET GROUP, LLC | $30 676 | 17 331 | 0,16% | Acciones |
| SIMPLEX TRADING, LLC | $27 785 | 15 698 | 0,15% | Acciones |
| UBS Group AG | $22 520 | 12 723 | 0,12% | Acciones |
| CITADEL ADVISORS LLC | $17 877 | 10 100 | 0,10% | Opción de venta |
| Persistent Asset Partners Ltd | $10 409 | 5 881 | 0,06% | Acciones |
| Cubist Systematic Strategies, LLC | $8 972 | 4 673 | 0,05% | Acciones |
| MORGAN STANLEY | $885 | 500 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $708 | 400 | 0,00% | Acciones |
| HRT FINANCIAL LP | $128 | 72 486 | 0,00% | Acciones |
| GROUP ONE TRADING LLC | $90 | 51 | 0,00% | Acciones |
| Virtu Financial LLC | $65 | 36 921 | 0,00% | Acciones |
| SG Americas Securities, LLC | $25 | 13 913 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N | 4 de agosto de 2026 | 9,99% | Presentación inicial | Campaña de la junta directiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 17 insiders · 4 directivos · 5 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Spiros Jamas | Chief Executive Officer | 18 de enero de 2022 P | 10 000 | 0 | 0 | $0 |
| Ramesh Ratan | U.S.based CFO | 19 de enero de 2022 P | 10 000 | 0 | 0 | $0 |
| Phillip Schwartz | President of R&D | 20 de enero de 2022 P | 607 410 | 0 | 0 | $0 |
| Arthur C Santora II | Chief Medical Officer | 24 de abril de 2023 A | · | 0 | 0 | $0 |
| Gerald M Ostrov | Consejero | 1 de enero de 2026 A | 75 657 | 0 | 0 | $0 |
| Gerald M Lieberman | Consejero | 1 de enero de 2026 A | 338 454 | 0 | 0 | $0 |
| Ron Mayron | Consejero | 1 de enero de 2024 A | 7 000 | 0 | 0 | $0 |
| Roger Garceau | Consejero | 1 de enero de 2024 A | · | 0 | 0 | $0 |
| Gregory Burshtein | · | 7 de agosto de 2026 A | 189 033 | 0 | 0 | $0 |
| Haya Taitel | · | 7 de agosto de 2026 A | 119 269 | 1 | 0 | $11 100 |
| Dana Yaacov-Garbeli | · | 7 de agosto de 2026 A | 171 441 | 0 | 0 | $0 |
| Yonatan Malca | · | 7 de agosto de 2026 A | 100 231 | 0 | 0 | $0 |
| Sean Ellis | · | 7 de agosto de 2026 A | 208 132 | 2 | 0 | $34 620 |
| Hillel Galitzer | · | 7 de agosto de 2026 A | 163 566 | 0 | 0 | $0 |
| Miranda Jayne Toledano | · | 7 de agosto de 2026 A | 847 135 | 1 | 0 | $19 910 |
| Geno J Germano | · | 7 de agosto de 2026 A | 65 014 | 2 | 0 | $55 800 |
| Steven D Rubin | · | 7 de agosto de 2026 A | 34 117 | 2 | 0 | $19 450 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
ENTX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 7 analistas
COMPRA
Objetivo mediano
$9.50
+232,2%
2 28,6%
Compra fuerte
4 57,1%
Compra
1 14,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
4 analistas · 2026-10-02Objetivo medio $9.75 +240,9%
← Por Debajo de Todos los Objetivos
Precio Actual $2.86
Mín$9.00
Media$9.75
Máx$11.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 7, 2026